BPC-157 has shown potential in supporting tissue repair, which could ultimately improve comfort and ocular health for dry eye sufferers
Blood test markers to discuss with a clinician Marker CBC with differential Why it matters Screens blood-cell patterns that may flag infection, anemia, or immune changes before interpreting repair symptoms
Most participants who experienced nausea during the initial titration phase reported significant improvement or complete resolution by weeks 4 to 8 at a stable dose
Nothing here is medical advice or a dosing recommendation
Phase 3 data and practical implications for your protocol Phase 3 data extended the timeline to 68 weeks and pushed peak weight loss to 28.7 percent, equivalent to 71.2 pounds or 32.3 kilograms in the highest-performing participants
Sample size in the hundreds, follow-up of several months, prespecified primary endpoint, independent funding or at least transparent funding disclosure, replication of key findings